A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
Kidney Cancer - Prostate Cancer - Bladder Cancer
Conditions: official terms
Carcinoma, Renal Cell - Kidney Neoplasms - Prostatic Neoplasms - Urinary Bladder Neoplasms
Conditions: Keywords
Kidney Cancer, Prostate Cancer, Bladder Cancer
Study Type
Study Phase
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age.

Exclusion Criteria:

- Patients under the age of 18
Meir Medical Center
Kvar Saba, Israel
Status: Recruiting
Contact: Daniel Kejzman, MD - 00972-9747-1606 - daniel.kejzman@clalit.org.il
Start Date
August 2014
Completion Date
August 2025
Meir Medical Center
Meir Medical Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page